Insider Transactions in Q2 2023 at Bridge Bio Pharma, Inc. (BBIO)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 17
2023
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
51,552
-1.06%
|
$721,728
$14.01 P/Share
|
|
May 17
2023
|
Brian C Stephenson Secretary, Treasurer & CFO |
SELL
Open market or private sale
|
Direct |
24,424
-40.15%
|
$341,936
$14.01 P/Share
|
|
May 16
2023
|
Charles J Homcy |
SELL
Payment of exercise price or tax liability
|
Direct |
1,300
-0.11%
|
$18,200
$14.09 P/Share
|
|
May 16
2023
|
Charles J Homcy |
BUY
Exercise of conversion of derivative security
|
Direct |
3,759
+0.31%
|
-
|
|
May 16
2023
|
Neil Kumar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
50,697
-1.03%
|
$709,758
$14.09 P/Share
|
|
May 16
2023
|
Neil Kumar Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
102,249
+2.04%
|
-
|
|
May 16
2023
|
Brian C Stephenson Secretary, Treasurer & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
20,572
-25.27%
|
$288,008
$14.09 P/Share
|
|
May 16
2023
|
Brian C Stephenson Secretary, Treasurer & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
44,996
+35.6%
|
-
|
|
May 03
2023
|
Brian C Stephenson Secretary, Treasurer & CFO |
SELL
Open market or private sale
|
Direct |
64,929
-64.07%
|
$909,006
$14.18 P/Share
|
|
May 03
2023
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
120,000
-10.59%
|
$1,680,000
$14.18 P/Share
|
|
Apr 05
2023
|
Brian C Stephenson Secretary, Treasurer & CFO |
SELL
Open market or private sale
|
Direct |
55,500
-35.39%
|
$832,500
$15.45 P/Share
|
|
Apr 05
2023
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
120,000
-9.58%
|
$1,800,000
$15.46 P/Share
|